Note

Earnings Roundup: MEDNAX (NYSE: MD)

On Thursday, Shares of MEDNAX (NYSE: MD) lost -1.05% to $29.32. The stock grabbed the investor’s attention and traded 1,247,561 shares as compared to its average daily volume of 1.29M shares. The stock’s institutional ownership stands at 96.00%.

Mednax Inc. (MD) stated fourth-quarter profit of $60.20M. The Sunrise, Florida-based Company said it had net income of 68 cents per share. Earnings, adjusted for amortization costs and stock option expense, came to 92 cents per share. The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 91 cents per share.

The physician group posted revenue of $932.70M in the period, which also beat Street forecasts. Eight analysts surveyed by Zacks expected $907.20M.

investment fraud lawyersRecover Your Investment Losses. Please Contact Haselkorn & Thibaut at 1 888-628-5590 or visit InvestmentFraudLawyers.com for a free consultation on recovering your investment loses.

For the year, the company stated profit of $268.60M, or $2.93 per share. Revenue was stated as $3.650B. For the current quarter ending in April, Mednax anticipates its per-share earnings to range from 67 cents to 75 cents.

MD has a market value of $2.57B while its EPS was booked as $2.93 in the last 12 months. The stock has 87.70M shares outstanding. Beta value of the company was 0.57; beta is used to measure riskiness of the security. Analyst recommendation for this stock stands at 2.50.

Scroll to Top